Top compounds associated with response to ADAM29


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.075 0.03
mRNA AZD-7545 CTRPv2 pan-cancer AAC 0.077 0.03
mRNA NPC-26 CTRPv2 pan-cancer AAC 0.081 0.03
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.067 0.03
mRNA PI-103 GDSC1000 pan-cancer AAC 0.063 0.03
mRNA Salubrinal GDSC1000 pan-cancer AAC -0.11 0.03
mRNA CBB-1007 CTRPv2 pan-cancer AAC 0.11 0.03
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.077 0.03
mRNA FR-180204 GDSC1000 pan-cancer AAC 0.07 0.03
mRNA Pyrimethamine GDSC1000 pan-cancer AAC -0.11 0.04
Download CSV